Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :15221005
Publication Date : //

Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas.


Hepatoblastoma is one of the most common malignant liver tumors in young children. Recent evidences have suggested that the abnormalities in Wnt signaling pathway, as seen in frequent mutation of the beta-catenin gene, may play a role in the genesis of hepatoblastoma. However, the precise mechanism to cause the tumor has been elusive. To identify novel hepatoblastoma-related genes for unveiling the molecular mechanism of the tumorigenesis, a large-scale cloning of cDNAs and differential screening of their expression between hepatoblastomas and the corresponding normal livers were performed. We constructed four full-length-enriched cDNA libraries using an oligo-capping method from the primary tissues which included two hepatoblastomas with high levels of alpha-fetoprotein (AFP), a hepatoblastoma without production of AFP, and a normal liver tissue corresponded to the tumor. Among the 10,431 cDNAs randomly picked up and successfully sequenced, 847 (8.1%) were the genes with unknown function. Of interest, the expression profile among the two subsets of hepatoblastoma and a normal liver was extremely different. A semiquantitative RT-PCR analysis showed that 86 out of 1188 genes tested were differentially expressed between hepatoblastomas and the corresponding normal livers, but that only 11 of those were expressed at high levels in the tumors. Notably, PLK1 oncogene was expressed at very high levels in hepatoblastomas as compared to the normal infant's livers. Quantitative real-time RT-PCR analysis for the PLK1 mRNA levels in 74 primary hepatoblastomas and 29 corresponding nontumorous livers indicated that the patients with hepatoblastoma with high expression of PLK1 represented significantly poorer outcome than those with its low expression (5-year survival rate: 55.9 vs 87.0%, respectively, p=0.042), suggesting that the level of PLK1 expression is a novel marker to predict the prognosis of hepatoblastoma. Thus, the differentially expressed genes we have identified may become a useful tool to develop new diagnostic as well as therapeutic strategies of hepatoblastoma.

Authors : Yamada Shin-ichi , Ohira Miki , Horie Hiroshi , Ando Kiyohiro , Takayasu Hajime , Suzuki Yutaka , Sugano Sumio , Hirata Takahiro , Goto Takeshi , Matsunaga Tadashi , Hiyama Eiso , Hayashi Yutaka , Ando Hisami , Suita Sachiyo , Kaneko Michio , Sasaki Fumiaki , Hashizume Kohei , Ohnuma Naomi , Nakagawara Akira ,

Related products :

Catalog number Product name Quantity
PK-PLK1-A010 Kinases: PLK1, protein, Expression system: Sf9 cells 10
B1088 Kligler Iron Agar,Modified USE For identification of Yersinia enterocolitica.Also used for differential identification of gram_negative enteric bacilli on the basis of fermentation of dextrose, lact Qty per Litre of Medium: 57,3
B1088 Kligler Iron Agar,Modified USE For identification of Yersinia enterocolitica.Also used for differential identification of gram_negative enteric bacilli on the basis of fermentation of dextrose, lact Qty per Litre of Medium: 57,3
B1088 Kligler Iron Agar,Modified USE : For identification of Yersinia enterocolitica.Also used for differential identification of gram-negative enteric bacilli on the basis of fermentation of dextrose, lact 5x500gm
RA630A-1 HT microRNA 419 Expression Profiling Assays 10 complete profiles
LY11701a PLK1 Over-expression Lysate
LY11701a PLK1 Over-expression Lysate 100ug
ABP-CS-PEBT002 Generation and Identification of Expression Positive Clone 1
0136 Expression Media Products: ExpressMax™ Screening Kit
0136 Expression Media Products ExpressMax™ Screening Kit
TM 036 BILE ESCULIN AGAR (for differential isolation & identification of 100 gm
TM 036 BILE ESCULIN AGAR (for differential isolation & identification of 500 gm
TM 036 BILE ESCULIN AGAR (for differential isolation & identification of 100 gm
TM 036 BILE ESCULIN AGAR (for differential isolation & identification of 500 gm
AP-3102 Signaling Cell Gene Expression: Human HIF-Regulated cDNA Profiling in Cell Lysates 4
AP-3102 Single Cell Gene Expression: Human HIF-Regulated cDNA Profiling in Cell Lysates 4
XGC-BiRDS-MiSeq-sRNA-Ref Bioinformatics analysis of MiSeq data: Comprehensive Small RNA Expression profiling Sample
XGC-BiRDS-NextSeq-sRNA-Ref Bioinformatics analysis of NextSeq 500 data: Comprehensive Small RNA Expression profiling Sample
XGC-BiRDS-HiSeq-sRNA-Ref Bioinformatics analysis of HiSeq 2000 data: Comprehensive Small RNA Expression profiling Sample
AP-3101 Single Cell Gene Expression: Human NFkB-Regulated cDNA Profiling in Cell Lysates 4
AP-3101 Signaling Cell Gene Expression: Human NFkB-Regulated cDNA Profiling in Cell Lysates 4
TM 141 KLIGLER IRON AGAR (for differential identification of gram negat 100 gm
TM 1085 SELLERS DIFFERENTIAL AGAR (for identification and differentiation of gram_neg 500 gm
TM 141 KLIGLER IRON AGAR (for differential identification of gram negat 500 gm
TM 141 KLIGLER IRON AGAR (for differential identification of gram negat 100 gm


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur